Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus
Clinical trial NCT04120623 · UNKNOWN
Trial details
- NCT number
- NCT04120623
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2019-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.